For example, Her2/neu has been used as the marker for breast cancer, prostate-specific antigen (PSA) for prostate cancer, CA125 for ovarian cancer, and CEA for colorectal, bladder, breast, pancreatic, and lung cancers [24,25]. This evidence concerns the gene KLK3 and prostate cancer.